JP2018118966A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018118966A5 JP2018118966A5 JP2018009249A JP2018009249A JP2018118966A5 JP 2018118966 A5 JP2018118966 A5 JP 2018118966A5 JP 2018009249 A JP2018009249 A JP 2018009249A JP 2018009249 A JP2018009249 A JP 2018009249A JP 2018118966 A5 JP2018118966 A5 JP 2018118966A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- hydroxypropyl
- substituted cellulose
- granules
- additives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000654 additive Substances 0.000 claims description 12
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 7
- 150000003951 lactams Chemical class 0.000 claims description 7
- 230000000996 additive effect Effects 0.000 claims description 6
- AYXYPKUFHZROOJ-ZETCQYMHSA-N pregabalin Chemical compound CC(C)C[C@H](CN)CC(O)=O AYXYPKUFHZROOJ-ZETCQYMHSA-N 0.000 claims description 5
- 229960001233 pregabalin Drugs 0.000 claims description 5
- 229920002472 Starch Polymers 0.000 claims description 4
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 claims description 4
- 235000013539 calcium stearate Nutrition 0.000 claims description 4
- 239000008116 calcium stearate Substances 0.000 claims description 4
- 235000010355 mannitol Nutrition 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- 239000006188 syrup Substances 0.000 claims description 3
- 235000020357 syrup Nutrition 0.000 claims description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims 12
- 229920002678 cellulose Polymers 0.000 claims 12
- 239000008187 granular material Substances 0.000 claims 9
- 239000011248 coating agent Substances 0.000 claims 7
- 238000000576 coating method Methods 0.000 claims 7
- 239000004480 active ingredient Substances 0.000 claims 6
- 239000003826 tablet Substances 0.000 claims 5
- 239000007888 film coating Substances 0.000 claims 4
- 238000009501 film coating Methods 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 229920000881 Modified starch Polymers 0.000 claims 3
- 108010010803 Gelatin Proteins 0.000 claims 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 2
- 229930006000 Sucrose Natural products 0.000 claims 2
- 229920000159 gelatin Polymers 0.000 claims 2
- 239000008273 gelatin Substances 0.000 claims 2
- 235000019322 gelatine Nutrition 0.000 claims 2
- 235000011852 gelatine desserts Nutrition 0.000 claims 2
- -1 hydroxypropyl Chemical group 0.000 claims 2
- 239000000463 material Substances 0.000 claims 2
- 239000006191 orally-disintegrating tablet Substances 0.000 claims 2
- 235000012239 silicon dioxide Nutrition 0.000 claims 2
- 239000005720 sucrose Substances 0.000 claims 2
- 150000005846 sugar alcohols Chemical group 0.000 claims 2
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 claims 1
- WSVLPVUVIUVCRA-KPKNDVKVSA-N Alpha-lactose monohydrate Chemical group O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O WSVLPVUVIUVCRA-KPKNDVKVSA-N 0.000 claims 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims 1
- 239000004386 Erythritol Substances 0.000 claims 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims 1
- 229920000084 Gum arabic Polymers 0.000 claims 1
- 229930195725 Mannitol Natural products 0.000 claims 1
- 239000004368 Modified starch Substances 0.000 claims 1
- 241000978776 Senegalia senegal Species 0.000 claims 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims 1
- 239000000205 acacia gum Substances 0.000 claims 1
- 235000010489 acacia gum Nutrition 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 claims 1
- 229940062672 calcium dihydrogen phosphate Drugs 0.000 claims 1
- 229910000389 calcium phosphate Inorganic materials 0.000 claims 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims 1
- 229960000913 crospovidone Drugs 0.000 claims 1
- JAUGGEIKQIHSMF-UHFFFAOYSA-N dialuminum;dimagnesium;dioxido(oxo)silane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[Mg+2].[Mg+2].[Al+3].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O JAUGGEIKQIHSMF-UHFFFAOYSA-N 0.000 claims 1
- 235000014113 dietary fatty acids Nutrition 0.000 claims 1
- 235000019414 erythritol Nutrition 0.000 claims 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims 1
- 229940009714 erythritol Drugs 0.000 claims 1
- 239000000194 fatty acid Substances 0.000 claims 1
- 229930195729 fatty acid Natural products 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 239000000905 isomalt Substances 0.000 claims 1
- 235000010439 isomalt Nutrition 0.000 claims 1
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 claims 1
- 239000000845 maltitol Substances 0.000 claims 1
- 235000010449 maltitol Nutrition 0.000 claims 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims 1
- 229940035436 maltitol Drugs 0.000 claims 1
- 239000000594 mannitol Substances 0.000 claims 1
- 235000019426 modified starch Nutrition 0.000 claims 1
- 235000019691 monocalcium phosphate Nutrition 0.000 claims 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 claims 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 claims 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 1
- 229940069328 povidone Drugs 0.000 claims 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 claims 1
- 239000000377 silicon dioxide Substances 0.000 claims 1
- 229960001866 silicon dioxide Drugs 0.000 claims 1
- 239000000600 sorbitol Substances 0.000 claims 1
- 235000010356 sorbitol Nutrition 0.000 claims 1
- 238000005507 spraying Methods 0.000 claims 1
- 239000000454 talc Substances 0.000 claims 1
- 229910052623 talc Inorganic materials 0.000 claims 1
- 229940033134 talc Drugs 0.000 claims 1
- 229960005196 titanium dioxide Drugs 0.000 claims 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims 1
- 238000003860 storage Methods 0.000 description 7
- 235000019658 bitter taste Nutrition 0.000 description 5
- 239000008186 active pharmaceutical agent Substances 0.000 description 4
- 229940088679 drug related substance Drugs 0.000 description 4
- 238000010828 elution Methods 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 229920000915 polyvinyl chloride Polymers 0.000 description 2
- 239000004800 polyvinyl chloride Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 229940079832 sodium starch glycolate Drugs 0.000 description 2
- 229920003109 sodium starch glycolate Polymers 0.000 description 2
- 239000008109 sodium starch glycolate Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017009736 | 2017-01-23 | ||
| JP2017009736 | 2017-01-23 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018118966A JP2018118966A (ja) | 2018-08-02 |
| JP2018118966A5 true JP2018118966A5 (enExample) | 2021-06-10 |
| JP6919119B2 JP6919119B2 (ja) | 2021-08-18 |
Family
ID=63043564
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018009249A Active JP6919119B2 (ja) | 2017-01-23 | 2018-01-23 | ３位が置換されたγ−アミノ酪酸誘導体を含有する圧縮固形医薬組成物。 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6919119B2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019146642A1 (ja) * | 2018-01-24 | 2019-08-01 | 大原薬品工業株式会社 | γ－アミノ酪酸誘導体含有錠剤の化学的安定性を改善する方法 |
| JP6504638B1 (ja) * | 2018-05-31 | 2019-04-24 | 武田テバファーマ株式会社 | 錠剤及びその製造方法 |
| WO2019244649A1 (ja) | 2018-06-22 | 2019-12-26 | ソニー株式会社 | 描画および消去装置ならびに消去方法 |
| WO2022168968A1 (ja) * | 2021-02-05 | 2022-08-11 | 学校法人近畿大学 | 末梢神経障害の予防又は改善剤 |
| CN115340427B (zh) * | 2022-03-10 | 2023-04-11 | 南开大学 | 一种赤铁矿-羧甲基纤维素-营养盐复合物及其制备方法和应用 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1077692T3 (da) * | 1998-05-15 | 2004-12-06 | Warner Lambert Co | Aminosyrestabiliserede gabapentin- og pregabalinpræparater og fremgangsmåder til fremstilling deraf |
| HU228772B1 (en) * | 1998-05-15 | 2013-05-28 | Warner Lambert Co | Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same |
| FR2781793B1 (fr) * | 1998-08-03 | 2001-07-20 | Prographarm Lab | Procede de fabrication de granules de gabapentine enrobes |
| FR2795962B1 (fr) * | 1999-07-08 | 2003-05-09 | Prographarm Laboratoires | Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif |
| BRPI0614021A2 (pt) * | 2005-01-21 | 2011-03-01 | Pharmanova Inc | formulações farmacêuticas e métodos de uso |
| NL2000281C2 (nl) * | 2005-11-02 | 2007-08-07 | Pfizer Prod Inc | Vaste farmaceutische samenstellingen die pregabaline bevatten. |
| DE102007019071A1 (de) * | 2007-04-23 | 2008-10-30 | Ratiopharm Gmbh | Stabilisierte pharmazeutische Zusammensetzung enthaltend Pregabalin |
| US8454993B2 (en) * | 2007-11-23 | 2013-06-04 | Lupin Limited | Controlled release pharmaceutical compositions of pregabalin |
| TR200909613A1 (tr) * | 2009-12-22 | 2011-07-21 | Sanovel İlaç San. Ve Ti̇c. A.Ş. | Pregabalinin farmasötik bileşimleri. |
| WO2011104652A2 (en) * | 2010-02-24 | 2011-09-01 | Pfizer Inc. | Veterinary compositions |
| HU230031B1 (hu) * | 2010-03-01 | 2015-05-28 | Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság | Pregabalint és izomaltot tartalmazó stabilizált gyógyszerkészítmény |
| EP2415460A1 (de) * | 2010-08-03 | 2012-02-08 | ratiopharm GmbH | Orale Darreichungsform von Pregabalin |
| KR101724024B1 (ko) * | 2011-07-26 | 2017-04-06 | 주식회사유한양행 | 2상 방출-제어 시스템에 의한 프레가발린을 함유하는 서방성 정제 |
| CN103385870A (zh) * | 2012-05-09 | 2013-11-13 | 鲁南制药集团股份有限公司 | 普瑞巴林的医药用途 |
| GB201301242D0 (en) * | 2013-01-24 | 2013-03-06 | Hofmeyr Phillip R | Tennis teaching aids |
| EP2826470B1 (en) * | 2013-07-19 | 2017-09-06 | Arven Ilac Sanayi ve Ticaret A.S. | Pharmaceutical combinations of pregabalin |
| IN2014MU00215A (enExample) * | 2014-01-22 | 2015-08-28 | Intas Pharmaceuticals Ltd | |
| CN104906064B (zh) * | 2015-05-15 | 2017-12-22 | 中国药科大学 | 一种普瑞巴林胃漂浮缓释片剂及其制备方法 |
| CN108478537A (zh) * | 2018-05-03 | 2018-09-04 | 南京易亨制药有限公司 | 一种含普瑞巴林的单室渗透泵控释片剂 |
-
2018
- 2018-01-23 JP JP2018009249A patent/JP6919119B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018118966A5 (enExample) | ||
| JP5352474B2 (ja) | 口腔内崩壊錠およびその製造方法 | |
| RU2153337C2 (ru) | Таблетка парацетамола и домперидона с пленочным покрытием | |
| JP2006516570A5 (enExample) | ||
| JP2019019128A (ja) | フィルムコーティング錠 | |
| CN105338970B (zh) | 包含他达拉非和坦洛新的药物胶囊复合制剂 | |
| JPS5883618A (ja) | ニトロフラントイン投与剤 | |
| JP2018118966A (ja) | ３位が置換されたγ−アミノ酪酸誘導体を含有する圧縮固形医薬組成物。 | |
| JP2010120959A5 (enExample) | ||
| JP7212484B2 (ja) | 腸溶性被覆顆粒の耐酸性が改善された圧縮成形製剤の製造方法 | |
| TW201318650A (zh) | 口崩片組成物 | |
| JP2010168287A (ja) | 内服用錠剤 | |
| JP5461084B2 (ja) | 崩壊遅延が抑制されたパロキセチン塩酸塩水和物の経口投与用医薬組成物 | |
| JP2010202579A (ja) | アカルボースを含有する口腔内崩壊剤 | |
| JP6271802B1 (ja) | 口腔内崩壊錠 | |
| JP7274825B2 (ja) | 錠剤及びその製造方法 | |
| JP2023099857A5 (enExample) | ||
| JP7419057B2 (ja) | 錠剤及びコーティング錠 | |
| WO2003075919A1 (fr) | Comprime contenant du chlorhydrate de pilsicainide (voie seche) | |
| JP2018030840A (ja) | 錠剤、コーティング錠、錠剤の製造方法及びコーティング錠の製造方法 | |
| JP7012492B2 (ja) | 錠剤およびその製造方法 | |
| JP5282644B2 (ja) | 内服用錠剤 | |
| WO2006070705A1 (ja) | ポビドンヨードを含有する口腔内崩壊型の固形製剤 | |
| JP2019089758A (ja) | セレコキシブ含有錠剤における溶出性の改善方法 | |
| JP7437039B2 (ja) | 錠剤 |